Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcuity RM Group plc Regulatory News (ACRM)

Share Price Information for Acuity RM Group plc (ACRM)

Share Price is delayed by 15 minutes
Get Live Data
0.75    -0.175 (-18.92%)
Bid:
0.70
Ask:
0.80
Spread: 0.10 (14.286%)
Market Cap: £1.83m
ACRM Live PriceLast checked at - London Stock Exchange

Intraday Acuity RM Group plc Share Chart

AGM Statement

10 Jul 2024 07:00

Acuity RM Group Plc - AGM Statement

Acuity RM Group Plc - AGM Statement

PR Newswire

LONDON, United Kingdom, July 10

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

10 July 2024

 

Acuity RM Group plc

 

(“Acuity”, or the “Company”)

 

Annual General Meeting Statement (“AGM”)

 

At the AGM to be held today Angus Forrest, Executive Chairman, will read the following statement to the meeting.

 

“The Company’s objective since the acquisition of Acuity Risk Management Ltd has been, and continues to be, to accelerate revenue growth. In the period several milestones have been achieved including large contract wins and a 45% increase in order values between 31 March 23 and 31 December 2023.

 

2023 Report & Accounts have been prepared using acquisition accounting as set out in IFRS 3 and as appropriate for Acuity’s new status as a trading company. In previous years the Company prepared accounts as an investing company.

 

Businesses are created and built by people. New management and talent were recruited in 2023 and this has continued through the first half of 2024. It takes time for change to take effect and the full benefits to be visible. The main changes have been made with some contribution expected in 2024 and they should be fully effective by mid 2025.

 

Notable achievements include:

 Orders won in H1 2024 -50% increase to £1,017,000 (H1 2023: £677,000)

Orders won in Q2 2024 - 81% increase to £693,000 (Q2 2023: £383,000) with several opportunities postponed until H2 2024 including three potential orders with a total value of £1,422,000.

Sales pipeline at 30 June 2024 -£7.9m (31 Dec £7.9m)

 First order from a US state in January 2024

 New partners in UK and US have been appointed

 Recruitment of:

  Finance director in Q4 2023

  Chief technical officer Q3 2023

  Experienced sales and marketing executives in Q2 2024

 

A recent development was the launch of a new counter terrorism product, STORM, in April 2024, at an event in the Houses of Parliament. STORM is believed to be the first product of its type and will enable event organisers to meet the requirements of anticipated legislation.

 

We expect to be able to announce an accelerating rate of order wins and developments in all areas of the business over the next 12 months. In particular we are redeveloping our core product, STREAM, so it incorporates the latest technologies, remains at the forefront of risk management software platforms available in the GRC market and has a suite of improvements built in to maintain its competitive edge.

 

Fund raise - £1 million was raised in June to invest in the developments outlined above. This should enable faster growth and increased value of orders which in turn should be reflected in improving financial results.”

 

 

For further information please contact:

 

 

Acuity RM Group Plc

www.acuityrmgroup.com

Angus Forrest

+44 (0) 20 3582 0566

 

 

WH Ireland (NOMAD & Broker)

www.whirelandcb.com

Mike Coe / Sarah Mather

020 7220 1666

 

 

Peterhouse Capital Limited (Joint broker)

 

Lucy Williams / Duncan Vasey

020 7469 0936

Clear Capital Markets Limited (Joint Broker)Bob Roberts

 020 3869 6080

 

Note to Editors

Acuity RM Group plc

Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services. Its award-winning software platform, STREAM®, which collects and analyses data about organisations to improve business decisions and management. It is used by around 70 organisations in markets including government, utilities, defence, broadcasting, manufacturing and healthcare.

 

The Company is focused on delivering long term, sustainable growth in shareholder value. In the short to medium term this is expected to come from organic growth and thereafter may also come from complementary acquisitions.

 

 



12
Date   Source Headline
17th Jun 20267:00 amPRNRetail Offer
16th Jun 20264:33 pmRNSFundraise of approximately £400,000
8th Jun 20267:00 amRNS-RContract Expansion
24th Apr 20267:00 amPRNTrading Statement
23rd Apr 20267:00 amPRNTrading Statement
27th Mar 20267:00 amPRNIssue of Equity
16th Mar 20267:00 amRNSProduct Launch
16th Mar 20267:00 amPRNProduct Launch
9th Mar 20267:00 amRNS-RA client’s experience of Acuity
24th Feb 20267:00 amRNS-RContract win
17th Feb 20267:00 amPRNContract
5th Feb 20262:35 pmPRNDirector/PDMR Shareholding
5th Feb 20261:17 pmPRNPDMR Shareholding
4th Feb 20267:00 amPRNHolding in Company
2nd Feb 20267:00 amPRNContract
15th Jan 20268:07 pmPRNHoldings in Company and Director Dealing
15th Jan 20267:00 amPRNStatement re Investor Presentation 10.00am 21 January
13th Jan 20267:00 amPRNTrading Statement
18th Nov 20258:47 amRNSHolding(s) in Company
17th Nov 20257:00 amPRNStatement re sale of investment
13th Nov 20254:06 pmPRNHolding(s) in Company
12th Nov 20257:00 amPRNDirectorate changes
21st Oct 20257:00 amRNS-RContract Win
7th Oct 20257:00 amPRNContract
22nd Sep 20257:00 amPRNIssue of Equity
16th Sep 20251:03 pmPRNHolding(s) in Company
5th Sep 20257:00 amPRNStatement re Investor presentation 10.00am 11 September
2nd Sep 20257:00 amPRNHalf-year Report
18th Aug 20257:00 amRNS-RFirst customer win for new product
30th Jul 20251:52 pmPRNResult of AGM
29th Jul 20257:00 amPRNIssue of Equity
11th Jul 202511:33 amPRNHolding(s) in Company
7th Jul 20254:09 pmPRNAnnual Report and Notice of AGM
7th Jul 202512:23 pmPRNHolding(s) in Company
7th Jul 20257:00 amPRNProduct Launch
4th Jul 202511:56 amPRNHolding(s) in Company
2nd Jul 20257:00 amPRNStatement re Final Results
30th Jun 20251:54 pmPRNIssue of Equity
26th Jun 20256:04 pmPRNHolding(s) in Company
25th Jun 20259:30 amRNSFinal Results
19th Jun 20253:22 pmPRNHolding(s) in Company
13th Jun 202510:30 amPRNStatement re Business and Directorate
21st May 20257:00 amPRNIssue of Equity
19th May 20259:45 amPRNIssue of Equity
19th May 20257:00 amPRNIssue of Equity
6th Mar 20257:00 amPRNStatement re Investor Presentation
17th Feb 20257:00 amPRNDirector/PDMR Shareholding
7th Feb 20257:00 amPRNChanges in share options
5th Feb 20258:59 amPRNCorrection to Year end Update
4th Feb 20257:00 amPRNTrading Statement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.